AIMCA
FOLD

Alberta Investment Management Corp (AIMCo)’s Amicus Therapeutics FOLD Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,389,200
Closed -$20.1M – 686
2026
Q1 		$20.1M Buy
1,389,200
+450,000
+48% +$6.45M 0.12% 114
2025
Q4 		$13.4M Buy
+939,200
New +$9.23M 0.08% 172
2023
Q3 		– Sell
-13,544
Closed -$170K – 1104
2023
Q2 		$170K Buy
+13,544
New +$161K ﹤0.01% 1158

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s FOLD Position: Q2 2026 in Review

Alberta Investment Management Corp (AIMCo) sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 1,389,200 shares — an estimated $20.1M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in FOLD in Q2 2023 and held it in 3 quarters. The position peaked at $20.1M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 1,389,200 Amicus Therapeutics shares in Q2 2026, an estimated $20.1M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Amicus Therapeutics in Q2 2023 and held it in 3 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Amicus Therapeutics position peaked at $20.1M in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2026, filed 6 Aug 2026.